![Paul Brenchley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Paul Brenchley is the founder of Renephra Ltd, a company he founded in 2009 where he held the position of Non-Executive Director.
Currently, he is a Professor at The University of Manchester.
Actieve functies van Paul Brenchley
Bedrijven | Functie | Begin |
---|---|---|
Renephra Ltd.
![]() Renephra Ltd. Miscellaneous Commercial ServicesCommercial Services Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom. | Oprichter | 01-01-2009 |
The University of Manchester | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Renephra Ltd.
![]() Renephra Ltd. Miscellaneous Commercial ServicesCommercial Services Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom. | Commercial Services |